Skip to content
healthcare.dev

Efavirenz, Emtricitabine And Tenofovir Disoproxil Fumarate

NDC 65862-497, Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, tablet, film coated, from Aurobindo Pharma Limited.

Product NDC
65862-497
Status
Listed
Labeler
Aurobindo Pharma Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203041
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65862-497 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EFAVIRENZ600 mg/1
  • EMTRICITABINE200 mg/1
  • TENOFOVIR DISOPROXIL FUMARATE300 mg/1

Pharmacologic classes

Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleoside Reverse Transcriptase Inhibitors [MoA]; Nucleosides [CS]; Nucleosides [CS]

Package NDCNDC-11Package
65862-497-306586204973030 TABLET, FILM COATED in 1 BOTTLE (65862-497-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1b71df95-b1ce-4e40-908a-67fb336457f4
  • NADAC price for package 65862049730

    GET /v1/drugs/nadac/65862049730

Use it

Look up 65862-497 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65862-497 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65862-497. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.